Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros













Base de datos
Intervalo de año de publicación
1.
Reprod Domest Anim ; 59(5): e14596, 2024 May.
Artículo en Inglés | MEDLINE | ID: mdl-38757656

RESUMEN

Chlorogenic acid (CGA) is an effective phenolic antioxidant that can scavenge hydroxyl radicals and superoxide anions. Herein, the protective effects and mechanisms leading to CGA-induced porcine parthenogenetic activation (PA) in early-stage embryos were investigated. Our results showed that 50 µM CGA treatment during the in vitro culture (IVC) period significantly increased the cleavage and blastocyst formation rates and improved the blastocyst quality of porcine early-stage embryos derived from PAs. Then, genes related to zygotic genome activation (ZGA) were identified and investigated, revealing that CGA can promote ZGA in porcine PA early-stage embryos. Further analysis revealed that CGA treatment during the IVC period decreased the abundance of reactive oxygen species (ROS), increased the abundance of glutathione and enhanced the activity of catalase and superoxide dismutase in porcine PA early-stage embryos. Mitochondrial function analysis revealed that CGA increased mitochondrial membrane potential and ATP levels and upregulated the mitochondrial homeostasis-related gene NRF-1 in porcine PA early-stage embryos. In summary, our results suggest that CGA treatment during the IVC period helps porcine PA early-stage embryos by regulating oxidative stress and improving mitochondrial function.


Asunto(s)
Ácido Clorogénico , Técnicas de Cultivo de Embriones , Desarrollo Embrionario , Mitocondrias , Estrés Oxidativo , Partenogénesis , Especies Reactivas de Oxígeno , Animales , Estrés Oxidativo/efectos de los fármacos , Partenogénesis/efectos de los fármacos , Mitocondrias/efectos de los fármacos , Técnicas de Cultivo de Embriones/veterinaria , Ácido Clorogénico/farmacología , Desarrollo Embrionario/efectos de los fármacos , Especies Reactivas de Oxígeno/metabolismo , Blastocisto/efectos de los fármacos , Porcinos , Potencial de la Membrana Mitocondrial/efectos de los fármacos , Antioxidantes/farmacología , Femenino , Glutatión/metabolismo
2.
Molecules ; 21(4): 514, 2016 Apr 21.
Artículo en Inglés | MEDLINE | ID: mdl-27110751

RESUMEN

Recent studies have shown that sulforaphane (SFN) selectively inhibits the growth of ALDH⁺ breast cancer stem-like cells.Herein, a series of SFN analogues were synthesized and evaluated against breast cancer cell lines MCF-7 and SUM-159, and the leukemia stem cell-like cell line KG-1a. These SFN analogues were characterized by the replacement of the methyl group with heterocyclic moieties, and the replacement of the sulfoxide group with sulfide or sulfone. A growth inhibitory assay indicated that the tetrazole analogs 3d, 8d and 9d were significantly more potent than SFN against the three cancer cell lines. Compound 14c, the water soluble derivative of tetrazole sulfide 3d, demonstrated higher potency against KG-1a cell line than 3d. SFN, 3d and 14c significantly induced the activation of caspase-3, and reduced the ALDH⁺ subpopulation in the SUM159 cell line, while the marketed drug doxrubicin(DOX) increased the ALDH⁺ subpopulation.


Asunto(s)
Ácidos Heterocíclicos/síntesis química , Ácidos Heterocíclicos/farmacología , Anticarcinógenos/síntesis química , Anticarcinógenos/farmacología , Ácidos Heterocíclicos/química , Aldehído Deshidrogenasa/metabolismo , Anticarcinógenos/química , Caspasa 3/metabolismo , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Isotiocianatos/química , Células MCF-7 , Sulfóxidos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA